Herstellung rekombinanter MEPE-Fragmente Deutschland

• 

  Herstellung rekombinanter MEPE-Fragmente

  This new way of protein production has made many new and exciting things possible. This means that proteins produced by this method can be highly effective in the production of pharmaceuticals. These medicines biopharmaceuticals are made from biological materials such as proteins, and can be used to treat serious findings such as cancer and diabetes and arthritis. This means more patients can get better treatment improving their health and quality of life with Yaohai  Fab Fragment Prozessentwicklung.

  
  

• 

  Erschließung neuer Anwendungen durch rekombinante Herstellung von MEPE-Fragmenten

  Neben Medikamenten produzieren die in Yaohai produzierten Proteine  Fab Fragment Prozessentwicklung can also be used to make food products. With so much potential, for example to produce proteins that are almost indistinguishable from the real taste and texture of meat in a fraction of the time it takes to grow whole animals on farms. This is especially significant because it enables the development of plant-based foods that are not only tastier but also more environmentally friendly than conventional meat products. 

  
  

• 

  Erläuterung zur Herstellung rekombinanter MEPE-Fragmente

  This short summary background on how to make targeted proteins is really scientific research to enable the ability of using genetic engineering in order for more understand what actually happened inside the process. These proteins from Yaohai  GLP-1-Fragmentproduktion sind für eine breite Palette von Anwendungen nützlich, von der Arzneimittelentwicklung bis zur Lebensmittelproduktion.

   

  
  

Warum sollten Sie sich für die Herstellung rekombinanter MEPE-Fragmente von Yaohai entscheiden?

• Robuste Lieferkette und Fertigungskapazitäten

  Yaohai Bio-Pharma, a top 10 manufacturer of biological products, specializes in microbial fermentation. We have created a Recombinant MEPE Fragment Manufacturing manufacturing facility with robust RD capabilities and cutting-edge manufacturing facilities. Five drug substance production lines conforming to GMP standards to purify and ferment microbial cells, as well as two fill and finish lines for vials and cartridges, as well as needles that are pre-filled, are available. The available fermentation scales include 100L, 500L, 1000L and 2000L. Specifications for filling vials range from 1ml - 25ml. the pre-filled cartridge or syringe filling specifications range from between 1-3ml. The production workshop is cGMP-compliant and provides a stable supply of commercial products and clinical samples. Our facility produces large molecules that are shipped worldwide.

• Fachkompetenz und langjährige Erfahrung

  Yaohai Bio-Pharma, a leader in CDMOs for microbial biologics, is located in Jiangsu. We are focusing on microbially produced therapeutics and vaccines that are Recombinant MEPE Fragment Manufacturing for human, veterinary as well as pet health management. We have the most cutting-edge RD platforms as well as manufacturing technology that cover the entire manufacturing process, from microbial strain development, cell banking, process and method development to clinical and commercial manufacture which ensures successful production of novel solutions. We have gained an extensive amount of experience in bio processing of microbial cells. More than 200 projects have been successfully completed, and we support our clients in get through regulations, such as those of US FDA as well as EU EMA. We also aid them with Australia TGA and China NMPA. Our experience and professional knowledge as well as our extensive knowledge allow us to quickly respond to market demands and provide customized CDMO services.

• Qualitätssystem und Einhaltung globaler Vorschriften

  Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Recombinant MEPE Fragment Manufacturing, Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Anpassung, Effizienz und Kosteneffizienz

  Yaohai Bio-Pharma is experienced in biologicals derived from microbial sources We offer bespoke RD solutions as well as manufacturing services while minimising potential risks We have been involved in numerous modalities like subunit vaccines recombinant peptides hormones cytokines growth factors single domain antibodies enzymes plasmid DNA the mRNA and other We've specialized in several microorganisms like yeast extracellular and intracellular Recombinant MEPE Fragment Manufacturing (yields up to 15g/L) and intracellular soluble bacteria and inclusion body (yields as high as 10g/L) We also have the BSL-2 fermentation platform to create bacterial vaccines We focus on optimizing processes increasing product yields and reducing costs We have an efficient technology team that guarantees timely and high-quality delivery of projects This helps us bring your unique products faster to market

Verwandte Produktkategorien

• AAV-Plasmidherstellung
• Analytische Methoden für Plasmid-DNA
• Herstellung des Bakteriophagen AP205 VLP
• Herstellung von Bakteriophage Q VLP
• Herstellung chimärer VLP-Impfstoffe
• Herstellung konjugierter VLP-Impfstoffe
• Herstellung von DNA-Impfstoffen
• E. coli-Fermentation zur VLP-Produktion
• Herstellung von GLP-1-Agonisten
• GLP-1 Analoge Fertigung

Finden Sie nicht, was Sie suchen?
Kontaktieren Sie unsere Berater für weitere verfügbare Produkte.